Pharma major Dr Reddy’s Laboratories Ltd has launched Finasteride tablets, a bioequivalent generic version of Propecia (Finasteride) tablets in the US market. The tablets are used for treating male pattern hair loss.
Dr. Reddy’s Abbreivated New Drug Application (ANDA) for Finasteride has been awarded a 180-day period of marketing exclusivity in the US on January 2, 2013, the Hyderabad-based company said in a release.
The Propecia tablets brand had US sales of approximately $136 million for the most recent 12 months ended in October 2012, according to IMS Health.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.